Overview
Vincenzo Adamo practices practicing medicine in Messina, Italy.
Mr. Adamo is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Ileostomy.
He is actively involved in clinical research, co-authoring 101 peer reviewed articles and participating in 2 clinical trials.
Gender
Locations
Messina, Italy
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Frequently Asked Questions about Vincenzo Adamo
Is Vincenzo Adamo a top-rated expert for Triple-Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Vincenzo Adamo is classified as an Distinguished expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Vincenzo Adamo participate in research or clinical trials?
Yes. Vincenzo Adamo has published 101 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Vincenzo Adamo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HER-2 Positive Breast CancerMr. Adamo isDistinguished. Learn about HER-2 Positive Breast Cancer.
- Lung CancerMr. Adamo isDistinguished. Learn about Lung Cancer.
- Triple-Negative Breast CancerMr. Adamo isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- Breast CancerMr. Adamo isAdvanced. Learn about Breast Cancer.
- EGFR Positive Lung CancerMr. Adamo isAdvanced. Learn about EGFR Positive Lung Cancer.
- Febrile NeutropeniaMr. Adamo isAdvanced. Learn about Febrile Neutropenia.
- IleostomyMr. Adamo isAdvanced. Learn about Ileostomy.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)Mr. Adamo isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- AgranulocytosisMr. Adamo isExperienced. Learn about Agranulocytosis.
- Bone TumorMr. Adamo isExperienced. Learn about Bone Tumor.
- Brain TumorMr. Adamo isExperienced. Learn about Brain Tumor.
- Colorectal CancerMr. Adamo isExperienced. Learn about Colorectal Cancer.
- COVID-19Mr. Adamo isExperienced. Learn about COVID-19.
- GallstonesMr. Adamo isExperienced. Learn about Gallstones.
- Inflammatory Breast CancerMr. Adamo isExperienced. Learn about Inflammatory Breast Cancer.
- Low Sodium LevelMr. Adamo isExperienced. Learn about Low Sodium Level.
- Lung AdenocarcinomaMr. Adamo isExperienced. Learn about Lung Adenocarcinoma.
- MenopauseMr. Adamo isExperienced. Learn about Menopause.
- Metastatic Brain TumorMr. Adamo isExperienced. Learn about Metastatic Brain Tumor.
- Renal Cell Carcinoma (RCC)Mr. Adamo isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)